Search Results - "Neel, Nicole F"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    LIM and SH3 protein-1 modulates CXCR2-mediated cell migration by Raman, Dayanidhi, Sai, Jiqing, Neel, Nicole F, Chew, Catherine S, Richmond, Ann

    Published in PloS one (19-04-2010)
    “…The chemokine receptor CXCR2 plays a pivotal role in migration of neutrophils, macrophages and endothelial cells, modulating several biological responses such…”
    Get full text
    Journal Article
  2. 2

    The RalB Small GTPase Mediates Formation of Invadopodia through a GTPase-Activating Protein-Independent Function of the RalBP1/RLIP76 Effector by Neel, Nicole F., Rossman, Kent L., Martin, Timothy D., Hayes, Tikvah K., Yeh, Jen Jen, Der, Channing J.

    Published in Molecular and Cellular Biology (01-04-2012)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  3. 3

    Chemokine receptor internalization and intracellular trafficking by Neel, Nicole F., Schutyser, Evemie, Sai, Jiqing, Fan, Guo-Huang, Richmond, Ann

    Published in Cytokine & growth factor reviews (01-12-2005)
    “…The internalization and intracellular trafficking of chemokine receptors have important implications for the cellular responses elicited by chemokine…”
    Get full text
    Journal Article
  4. 4

    IQGAP1 is a novel CXCR2-interacting protein and essential component of the "chemosynapse" by Neel, Nicole F, Sai, Jiqing, Ham, Amy-Joan L, Sobolik-Delmaire, Tammy, Mernaugh, Raymond L, Richmond, Ann

    Published in PloS one (18-08-2011)
    “…Chemotaxis is essential for a number of physiological processes including leukocyte recruitment. Chemokines initiate intracellular signaling pathways necessary…”
    Get full text
    Journal Article
  5. 5

    Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells by UEDA, Yukiko, NEEL, Nicole F, SCHUTYSER, Evemie, RAMAN, Dayanidhi, RICHMOND, Ann

    Published in Cancer research (Chicago, Ill.) (01-06-2006)
    “…The CXC chemokine receptor 4 (CXCR4) contributes to the metastasis of human breast cancer cells. The CXCR4 COOH-terminal domain (CTD) seems to play a major…”
    Get full text
    Journal Article
  6. 6

    RhoB plays an essential role in CXCR2 sorting decisions by Neel, Nicole F, Lapierre, Lynne A, Goldenring, James R, Richmond, Ann

    Published in Journal of cell science (01-05-2007)
    “…The CXCR2 chemokine receptor is a G-protein-coupled receptor that undergoes clathrin-mediated endocytosis upon ligand binding. The trafficking of CXCR2 is…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2 by Yu, Yingchun, Su, Yingjun, Opalenik, Susan R., Sobolik‐Delmaire, Tammy, Neel, Nicole F., Zaja‐Milatovic, Snjezana, Short, Sarah T., Sai, Jiqing, Richmond, Ann

    Published in Journal of leukocyte biology (01-08-2008)
    “…CXCR2 plays an important role during cutaneous wound healing. Transgenic mice were generated using the keratin‐14 promoter/enhancer to direct expression of…”
    Get full text
    Journal Article
  10. 10

    Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation by Neel, Nicole F, Stratford, Jeran K, Shinde, Vaishali, Ecsedy, Jeffrey A, Martin, Timothy D, Der, Channing J, Yeh, Jen Jen

    Published in Molecular cancer therapeutics (01-01-2014)
    “…The high prevalence of KRAS mutations and importance of the RalGEF-Ral pathway downstream of activated K-ras in pancreatic ductal adenocarcinoma (PDAC)…”
    Get full text
    Journal Article
  11. 11

    VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis by Neel, Nicole F, Barzik, Melanie, Raman, Dayanidhi, Sobolik-Delmaire, Tammy, Sai, Jiqing, Ham, Amy J, Mernaugh, Raymond L, Gertler, Frank B, Richmond, Ann

    Published in Journal of cell science (01-06-2009)
    “…Chemotaxis regulates the recruitment of leukocytes, which is integral for a number of biological processes and is mediated through the interaction of…”
    Get full text
    Journal Article
  12. 12

    The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery by Neel, Nicole F, Martin, Timothy D, Stratford, Jeran K, Zand, Tanya P, Reiner, David J, Der, Channing J

    Published in Genes & cancer (01-03-2011)
    “…The high frequency of RAS mutations in human cancers (33%) has stimulated intense interest in the development of anti-Ras inhibitors for cancer therapy…”
    Get full text
    Journal Article
  13. 13

    Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse" by Raman, Dayanidhi, Neel, Nicole F, Sai, Jiqing, Mernaugh, Raymond L, Ham, Amy-Joan L, Richmond, Ann J

    Published in Methods in enzymology (2009)
    “…Chemokine-receptor signaling is initiated upon ligand binding to the receptor and continues through the process of endocytic trafficking by the association of…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Abstract C15: Therapeutic benefit of targeting ERK in mutant KRAS in pancreatic ductal adenocarcinoma (PDAC) by Hayes, Tikvah K., Neel, Nicole F., Chenard, Melissa, Yeh, Jen Jen, Samatar, Ahmed, Der, Channing J.

    Published in Cancer research (Chicago, Ill.) (01-10-2013)
    “…Abstract The limited success of anti-MEK and anti-RAF therapies with KRAS mutant cancers has been attributed, in part, to de novo or acquired resistance…”
    Get full text
    Journal Article
  16. 16

    Abstract C188: RalA phosphorylation as a biomarker in pancreatic ductal adenocarcinoma for Aurora A kinase inhibition in response to the investigational agent MLN8237 by Neel, Nicole F., Escedy, Jeffrey A., Shinde, Vaishali, Der, Channing J., Yeh, Jen Jen

    Published in Molecular cancer therapeutics (12-11-2011)
    “…Abstract The frequent mutational activation of KRAS in pancreatic ductal adenocarcinoma (PDAC) (greater than 90%) and critical importance of K-Ras-driven…”
    Get full text
    Journal Article